The hypothesis underlying this proposal is that cannabinoids are endogenous neuroprotectants in cerebral ischemia. This hypothesis is based on several distinct observations, which include the fact that physiological events that occur during cerebral ischemia would be expected to enhance the synthesis and release of endogenous cannabinoids. Exogenously administered synthetic cannabinoid analogs can protect neuronal cultures from ischemia-like conditions, can reduce hippocampal neuronal loss after transient global ischemia, and can reduce infarct volume after permanent MCA occlusion in rat brain. Furthermore these neuroprotective actions of cannabinoids are in keeping with their ability to reduce voltage-gated calcium currents, enhance inwardly rectifying potassium currents, and inhibit glutamate release.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS039912-03
Application #
6499455
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Jacobs, Tom P
Project Start
2000-04-15
Project End
2005-01-31
Budget Start
2002-02-01
Budget End
2003-01-31
Support Year
3
Fiscal Year
2002
Total Cost
$450,116
Indirect Cost
Name
Buck Institute for Age Research
Department
Type
DUNS #
800772162
City
Novato
State
CA
Country
United States
Zip Code
94945
Muccioli, Giulio G; Stella, Nephi (2008) An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. Anal Biochem 373:220-8
Wang, Jiou; Caruano-Yzermans, Amy; Rodriguez, Angela et al. (2007) Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability. J Biol Chem 282:345-52
Greenberg, David A (2007) Neurogenesis and stroke. CNS Neurol Disord Drug Targets 6:321-5
Greenberg, David A; Jin, Kunlin (2007) Regenerating the brain. Int Rev Neurobiol 77:1-29
Kim, Sun Hee; Won, Seok Joon; Mao, Xiao Ou et al. (2006) Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. J Pharmacol Exp Ther 319:150-4
Kim, Sun Hee; Won, Seok Joon; Mao, Xiao Ou et al. (2005) Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. J Pharmacol Exp Ther 313:88-94
Jin, Kunlin; Xie, Lin; Kim, Sun Hee et al. (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66:204-8
Franklin, Allyn; Parmentier-Batteur, Sophie; Walter, Lisa et al. (2003) Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23:7767-75
Parmentier-Batteur, Sophie; Jin, Kunlin; Xie, Lin et al. (2002) DNA microarray analysis of cannabinoid signaling in mouse brain in vivo. Mol Pharmacol 62:828-35
Parmentier-Batteur, Sophie; Jin, Kunlin; Mao, Xiao Ou et al. (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22:9771-5

Showing the most recent 10 out of 11 publications